INVRAGEN (INV-DEN-203)

A double-blind, randomized, placebo-controlled, age descending and expansion Phase 2 study to investigate the safety and immunogenicity of a tetravalent chimeric dengue vaccine in healthy volunteers between the ages of 1.5 – 45 years

Archives

Trials Status

Founded by physicians in 2006, LCTC Inc., provides an attractive source for conducting phase III-IV clinical research funded by Pharmaceutical, Biotech Companies, Contract Research Organizations or NIH funded trials.
Latin Clinical Trial Center
1801 Ponce de Leon Ave,
Suite 205, San Juan, PR 00909
787-249-4763 (24/7)
787-985-9911
Fax: 787-982-7100
© 2023 Latin Clinical Trial Center. All Rights Reserved.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram